by Lori Solomon The U.S. Food and Drug Administration has approved Journey Medical’s Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults. The extended-release capsules (40 mg) will be available late in the first quarter or early in the second quarter of 2025. The approval was based on positive results from two 16-week...
Tag: <span>FDA approve</span>
Post
FDA approves prescription-only Apple Watch app for PTSD nightmares
By Rich Haridy, November 10, 2020 A new prescription-only system uses an Apple Watch to detect and disrupt nightmares through gentle vibrations without waking the user NightWare The majority of post-traumatic stress disorder (PTSD) patients suffer from frequent traumatic nightmares that can deeply disrupt sleep patterns and have been linked with significantly higher rates of...